Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection
Reported byGood News Network ↗·Sourced by Goodlede
PURPOSE 1 trial demonstrated zero new HIV infections among 3,200 participants receiving twice-yearly lenacapavir injections. This reflects real clinical trial data from a legitimate Phase 2b/3 study published in peer-reviewed literature (NEJM, 2023).
Does not prove 100% effectiveness in all populations; trial participants were selected high-risk groups with good adherence; real-world effectiveness depends on consistent adherence to twice-yearly schedule; long-term safety data still emerging; cost/access barriers not addressed.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at Good News Network
Read original story ↗↻ Refreshed daily
More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede